v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Consolidated net income $ 107.1 $ 78.5
Adjustments to reconcile consolidated net income to net cash flows from operating activities:    
Depreciation and amortization 51.7 47.3
Deferred income taxes (12.7) (6.9)
Stock-based compensation expense 10.8 9.1
Provision for credit losses 1.8 2.5
Equity in investments of unconsolidated entities 0.1 2.6
Other, net 0.1 (1.1)
Changes in operating assets and liabilities:    
Accounts receivable (9.0) 17.3
Accounts payable and accrued liabilities 6.7 0.2
Accrued compensation and deferred commissions (138.7) (120.5)
Income taxes 20.3 20.1
Deferred revenue 63.7 47.9
Other assets and liabilities (10.4) (6.0)
Cash provided by operating activities 91.5 91.0
Investing activities    
Purchases of investment securities (10.7) (3.3)
Proceeds from maturities and sales of investment securities 23.9 4.5
Capital expenditures (37.9) (32.2)
Acquisitions, net of cash acquired (359.6) (38.5)
Purchases of investments in unconsolidated entities (0.1) (1.2)
Cash used for investing activities (384.4) (70.7)
Financing activities    
Common shares repurchased (300.0) (109.6)
Dividends paid (19.9) (19.5)
Proceeds from revolving credit facility 295.0 145.0
Repayment of revolving credit facility (30.0) (40.0)
Proceeds from term facility 375.0 0.0
Employee taxes withheld for stock awards (0.8) 0.0
Other, net (2.4) 0.0
Cash provided by (used for) financing activities 316.9 (24.1)
Effect of exchange rate changes on cash and cash equivalents (5.7) 12.6
Net increase in cash and cash equivalents 18.3 8.8
Cash and cash equivalents—beginning of period 474.5 502.7
Cash and cash equivalents—end of period 492.8 511.5
Supplemental disclosure of cash flow information    
Cash paid for income taxes 26.8 14.2
Cash paid for interest $ 12.3 $ 6.4